TY - JOUR
T1 - Changes in Brain-Health Related Modifiable Risk Factors in Older Adults After One Year of COVID-19-Restrictions
AU - Waterink, L.
AU - Bakker, E.D.
AU - Visser, L.N.C.
AU - Mangialasche, F.
AU - Kivipelto, M.
AU - Deckers, K.
AU - Kohler, S.
AU - Sikkes, S.A.M.
AU - Prins, N.D.
AU - Scheltens, P.
AU - van der Flier, W.M.
AU - Zwan, M.D.
N1 - Funding Information:
Research of Alzheimer Center Amsterdam is part of the Neurodegeneration Research Program of Amsterdam Neuroscience. Alzheimer Center Amsterdam was supported by the Stichting Alzheimer Nederland and Stichting VUmc Fonds. The Dutch Brain Research Registry ( Hersenonderzoek.nl ) was supported by the ZonMw-Memorabel (project no 73305095003), Alzheimer Nederland, Amsterdam Neuroscience, and Hersenstichting (Dutch Brain Foundation). LW was appointed at the public-private NWO cross-over project MOCIA (#17611). EB was appointed at ZonMW COVID-19 project POLAR (#10430 03201 0004). MK and FM were supported by the following funding: Center for Innovative Medicine (CIMED) at Karolinska Institutet, Sweden. MK, FM, PS, and MZ were recipients of Joint Program of Neurodegenerative Disorders – (EU-FINGERS: multimodal precision prevention toolbox for dementia in Alzheimer’s disease) grant through the following funding organizations under the aegis of JPND – www.jpnd.eu : Academy of Finland, Finland; Federal Ministry of Education and Research, Germany; National Institute of Health Carlos III, Spain; National Research Fund, Luxembourg; National Research, Development and Innovation Office, Hungary; Netherlands Organisation for Health Research and Development, Netherlands (ZonMW-Memorabel #733051102); Swedish Research Council, Sweden. MK was also supported by the Stiftelsen Stockholms Sjukhem, Sweden, and Academy of Finland. LV, SK, NP, PS, WF, and MZ were recipients of ABOARD, which is a public-private partnership receiving funding from ZonMW (#73305095007) and Health∼Holland, Top Sector Life Sciences & Health (PPP-allowance; #LSHM20106). SS is recipient of Health∼Holland, Top Sector Life Sciences and Health (PPP-allowance; #LSHM LSHM20084). The chair of WF was supported by the Pasman Stichting.
Funding Information:
The World-Wide-FINGERS-SARS-CoV-2 survey has been developed by MK’s team (FINGERS Brain Health Institute, Karolinska Institute, Sweden; University of Eastern Finland; Finnish National Institute for Health and Welfare and Imperial College London, United Kingdom). The FINGERS Brain Health Institute was supported by the Alzheimer’s Disease Data Initiative. Special thanks to M. A. Dubbelman and J. Tomassen for designing the figures.
Funding Information:
Research of Alzheimer Center Amsterdam is part of the Neurodegeneration Research Program of Amsterdam Neuroscience. Alzheimer Center Amsterdam was supported by the Stichting Alzheimer Nederland and Stichting VUmc Fonds. The Dutch Brain Research Registry (Hersenonderzoek.nl) was supported by the ZonMw-Memorabel (project no 73305095003), Alzheimer Nederland, Amsterdam Neuroscience, and Hersenstichting (Dutch Brain Foundation). LW was appointed at the public-private NWO cross-over project MOCIA (#17611). EB was appointed at ZonMW COVID-19 project POLAR (#10430 03201 0004). MK and FM were supported by the following funding: Center for Innovative Medicine (CIMED) at Karolinska Institutet, Sweden. MK, FM, PS, and MZ were recipients of Joint Program of Neurodegenerative Disorders – (EU-FINGERS: multimodal precision prevention toolbox for dementia in Alzheimer’s disease) grant through the following funding organizations under the aegis of JPND – www.jpnd.eu : Academy of Finland, Finland; Federal Ministry of Education and Research, Germany; National Institute of Health Carlos III, Spain; National Research Fund, Luxembourg; National Research, Development and Innovation Office, Hungary; Netherlands Organisation for Health Research and Development, Netherlands (ZonMW-Memorabel #733051102); Swedish Research Council, Sweden. MK was also supported by the Stiftelsen Stockholms Sjukhem, Sweden, and Academy of Finland. LV, SK, NP, PS, WF, and MZ were recipients of ABOARD, which is a public-private partnership receiving funding from ZonMW (#73305095007) and Health∼Holland, Top Sector Life Sciences & Health (PPP-allowance; #LSHM20106). SS is recipient of Health∼Holland, Top Sector Life Sciences and Health (PPP-allowance; #LSHM LSHM20084). The chair of WF was supported by the Pasman Stichting.
Publisher Copyright:
Copyright © 2022 Waterink, Bakker, Visser, Mangialasche, Kivipelto, Deckers, Köhler, Sikkes, Prins, Scheltens, Flier and Zwan.
PY - 2022/6/2
Y1 - 2022/6/2
N2 - BackgroundThe COVID-19 pandemic has major influence on lifestyle and mental health, which might affect brain-health and increase the risk of cognitive decline, particularly in older adults. We aimed to describe changes in modifiable risk factors related to brain-health in older adults after one year of COVID-19 restrictions. MethodsAn online survey was disseminated between February and March 2021 to 17,773 registrants of the Dutch Brain Research Registry, aged >= 50, without a self-reported diagnosis of mild cognitive impairment or dementia. Participants were asked to report potential changes in behaviors during the COVID-19 pandemic, compared to pre-pandemic, in eight domains related to brain health: physical activity, sleep, feeling of memory decline, perceived stress, feeling of loneliness, diet, alcohol consumption, and smoking. We used negative binomial regression analyses to relate (socio)demographics, subjective memory complaints and COVID-19 related aspects (fear of, or current/past COVID-19 infection) to the number of reported detrimental and beneficial changes as dependent variable. Results3,943 participants (66 +/- 8 years old; 76% female; 71% highly educated) completed the survey. After one year of COVID-19-restrictions, 74% reported at least one detrimental lifestyle change unfavorable for their brain health, most frequently reported were feelings of loneliness, sleep problems, and less physical activity. 60% of participants reported at least one beneficial change, which were most often more physical activity, healthier dietary habits, and less alcohol consumption. Individuals who are younger [incidence rate ratio (IRR) = 0.99, 95% CI = 0.98-0.99], female (1.20, 1.11-1.30), living alone (1.20, 1.11-1.28) and in urban environments (1.18, 1.08-1.29), who are less satisfied with their income (1.38, 1.17-1.62), experiencing subjective memory complaints (1.40, 1.28-1.52) and those with a past or current (1.19, 1.06-1.34) or fear of a COVID-19 infection (1.33, 1.25-1.42) reported higher numbers of detrimental changes. DiscussionThe COVID-19 pandemic has influenced lifestyle in both positive and negative ways. We identified (socio)demographic factors associated with more detrimental changes in modifiable risk factors related to brain health, suggesting that some individuals are more vulnerable for the impact of the COVID-19 pandemic. These findings provide an opportunity for targeted prevention and education to promote a healthy lifestyle during and after the pandemic.
AB - BackgroundThe COVID-19 pandemic has major influence on lifestyle and mental health, which might affect brain-health and increase the risk of cognitive decline, particularly in older adults. We aimed to describe changes in modifiable risk factors related to brain-health in older adults after one year of COVID-19 restrictions. MethodsAn online survey was disseminated between February and March 2021 to 17,773 registrants of the Dutch Brain Research Registry, aged >= 50, without a self-reported diagnosis of mild cognitive impairment or dementia. Participants were asked to report potential changes in behaviors during the COVID-19 pandemic, compared to pre-pandemic, in eight domains related to brain health: physical activity, sleep, feeling of memory decline, perceived stress, feeling of loneliness, diet, alcohol consumption, and smoking. We used negative binomial regression analyses to relate (socio)demographics, subjective memory complaints and COVID-19 related aspects (fear of, or current/past COVID-19 infection) to the number of reported detrimental and beneficial changes as dependent variable. Results3,943 participants (66 +/- 8 years old; 76% female; 71% highly educated) completed the survey. After one year of COVID-19-restrictions, 74% reported at least one detrimental lifestyle change unfavorable for their brain health, most frequently reported were feelings of loneliness, sleep problems, and less physical activity. 60% of participants reported at least one beneficial change, which were most often more physical activity, healthier dietary habits, and less alcohol consumption. Individuals who are younger [incidence rate ratio (IRR) = 0.99, 95% CI = 0.98-0.99], female (1.20, 1.11-1.30), living alone (1.20, 1.11-1.28) and in urban environments (1.18, 1.08-1.29), who are less satisfied with their income (1.38, 1.17-1.62), experiencing subjective memory complaints (1.40, 1.28-1.52) and those with a past or current (1.19, 1.06-1.34) or fear of a COVID-19 infection (1.33, 1.25-1.42) reported higher numbers of detrimental changes. DiscussionThe COVID-19 pandemic has influenced lifestyle in both positive and negative ways. We identified (socio)demographic factors associated with more detrimental changes in modifiable risk factors related to brain health, suggesting that some individuals are more vulnerable for the impact of the COVID-19 pandemic. These findings provide an opportunity for targeted prevention and education to promote a healthy lifestyle during and after the pandemic.
KW - COVID-19
KW - lifestyle
KW - mental health
KW - aging
KW - risk factors
KW - cognitive decline
KW - prevention
KW - lockdown
KW - DEMENTIA PREVENTION
KW - INTERVENTION
U2 - 10.3389/fpsyt.2022.877460
DO - 10.3389/fpsyt.2022.877460
M3 - Article
C2 - 35722572
SN - 1664-0640
VL - 13
JO - Frontiers in Psychiatry
JF - Frontiers in Psychiatry
M1 - 877460
ER -